MedTrace Logo

Clinical Efficacy of Mouthrinses Based on Chlorhexidine 0.12% and CITROX®

NCT06341439 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2025-03-21

No results posted yet for this study

Summary

The goal of the following clinical trial is to compare the efficacy of a product based on chlorhexidine 0.12% and CITROX and the same product without CITROX in the healing phenomena that occur after non-surgical periodontal therapy. The main questions it aims to answer are:

* Is the response to periodontal therapy better if mouthwashes containing bioflavonoids are used as a support to non surgical periodontal therapy?
* What is the patients' perception?

Participants, divided into 2 groups, are asked to use either one or the other mouthwash for 14 days after non-surgical periodontal therapy.

Conditions

  • Periodontitis

Interventions

DEVICE

Mouthwash with chlorhexidine 0,12% and CITROX

Patients use the undiluted mouthwash 2 times a day for 14 days after performing normal brushing.

DEVICE

Mouthwash with chlorhexidine 0,12%

Patients use the undiluted mouthwash 2 times a day for 14 days after performing normal brushing.

Sponsors & Collaborators

  • University of L'Aquila

    lead OTHER

Principal Investigators

  • Enrico Marchetti, DDS, MS, PhD · University of L'Aquila

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-01
Primary Completion
2024-06-01
Completion
2025-02-28

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06341439 on ClinicalTrials.gov